ProQR (PRQR) Prices 13.846M Share Common Offering at $6.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
After-Hours Stock Movers 03/30: (SURF) (CASI) (CHWY) Higher; (NMTR) (OSMT) (BB) Lower (more...)
March 30, 2021 5:42 PM EDTAfter-Hours Stock Movers:
Surface Oncology (Nasdaq: SURF) 14.5% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for one of the companys lead therapeutic candidates, SRF617, for the treatment of patients with pancreatic cancer.
ProQR (PRQR) Announces Proposed Underwritten Public Offering of Ordinary Shares
March 30, 2021 4:06 PM EDTProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced that it intends to offer and sell its ordinary shares in an underwritten public offering. All... More
